cenobamate plasma concentrations in 50% and 100% responders
Published 2 years ago • 72 plays • Length 4:47Download video MP4
Download video MP3
Similar videos
-
4:37
cenobamate in different epilepsy populations & with different medications
-
2:41
predictors of maintained response to cenobamate in patients with epilepsy
-
2:23
cenobamate therapy reduces concomitant drug load in patients with epilepsy
-
5:29
post-hoc analysis of c017: efficacy and safety of cenobamate
-
6:27
cenobamate as a promising treatment for patients with epilepsy
-
6:30
how to treat epilepsy, 10 tips from the epileptologist
-
14:09
how to end seizures (epilepsy) once and for all
-
12:22
acupuncture and epilepsy
-
2:55
cenobamate for focal seizures: longer-term efficacy and adverse events
-
1:16
insights from cenobamate studies
-
8:56
long-term efficacy of cenobamate in patients with uncontrolled focal seizures
-
3:14
challenges with cenobamate use in focal epilepsy
-
7:01
early and sustained responses to cenobamate across focal seizure subtypes
-
1:40
long-term efficacy of adjunctive cenobamate in patients with focal seizures
-
7:02
how to manage patients receiving adjunctive cenobamate
-
9:07
practical recommendations on cenobamate for epilepsy
-
7:19
sudep rates in the cenobamate development program
-
13:45
cenobamate (xcopri). very effective new epilepsy medicine
-
5:36
how will the role of cenobamate evolve in the epilepsy space?
-
0:21
cenobamate (xcopri) for epilepsy
-
1:11
concomitant asm dose reductions in clinical trial of adjunctive cenobamate for focal seizures
-
2:38
cognitive and psychiatric adverse events associated with cenobamate